Benzodiazepine Dependence
14
3
3
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
14.3%
2 terminated out of 14 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
67%
4 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence
Promoting Benzodiazepine Cessation Through an Electronically-delivered Patient Self-management Intervention
Anxiety Lowering and Deprescribing Through Emotion Regulation
Benzodiazepine Impact on Cognitive Function: fNIRs and PET/MRI Study
Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT
Effectiveness of a Joint General Practitioner-Pharmacist Intervention on Benzodiazepine Deprescribing in the Elderly
Prevention of Benzodiazepine Misuse in Primary Care
Blended Care for the Discontinuation of Benzodiazepine Use
The Effect of Self-Forgiveness on Self-Stigma in Addiction.
Electronic Deprescribing Tool for the Prevention of PIP
Gabapentin Treatment of Benzodiazepine Dependence
Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients
Electroacupuncture for Tapering Off Long-term Benzodiazepine Use
Effectiveness of Mindfulness Based Relapse Prevention for Chronic Users of Benzodiazepines